Want to see IL:NVLG full AI Analyst Report?
NVLG Stock Chart & Stats
76.50
0.20(0.26%)
At close: 4:00 PM EDT
76.50
0.20(0.26%)
Day’s Range― - ―
52-Week Range66.30 - 154.63
Previous CloseN/A
Volume545.85K
Average Volume (3M)641.09K
Market Cap
₪412.79M
Enterprise Value355.02
Total Cash (Recent Filing)₪204.46M
Total Debt (Recent Filing)₪171.19M
Price to Earnings (P/E)―
Beta0.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.89%
Share Statistics
EPS (TTM)N/A
Shares Outstanding510,874,760
10 Day Avg. Volume285,794
30 Day Avg. Volume641,093
Financial Highlights & Ratios
PEG Ratio-1.73
Price to Book (P/B)1.80
Price to Sales (P/S)0.36
P/FCF Ratio-18.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong TTM Revenue GrowthThe sharp TTM revenue increase indicates stronger distribution activity and market demand. If sustained, expanding scale can improve operating leverage and strengthen Novolog’s competitive position, although profitability must catch up.
Rebounded Operating Cash FlowPositive operating and free cash flow provide internal funding for operations, working capital and investment without relying entirely on external financing. This improves financial resilience, despite the reported volatility in year-to-year cash conversion.
Manageable LeverageModerate leverage and a substantial equity base limit balance-sheet pressure and preserve financing flexibility. This gives Novolog capacity to manage operating volatility and support growth, provided weak profitability does not persist.
Bears Say
Negative TTM EarningsThe move to a TTM net loss shows that revenue growth is not currently translating into reliable shareholder earnings. Persistent losses could restrict reinvestment, weaken financial flexibility and make the business more vulnerable to operating setbacks.
Margin CompressionLower gross and operating margins reduce the profit captured from each unit of distribution revenue. Unless Novolog restores pricing, product mix or cost efficiency, future growth may continue to produce limited earnings and cash returns.
Volatile Cash ConversionThe rebound in cash generation is encouraging but not yet demonstrably durable because free cash flow has fluctuated sharply between periods. Such volatility complicates planning and reduces confidence in the company’s ability to fund growth consistently.
Novolog News
NVLG FAQ
What was Novolog (Pharm UP 1966) Ltd.’s price range in the past 12 months?
Novolog (Pharm UP 1966) Ltd. lowest stock price was 66.30 and its highest was 154.63 in the past 12 months.
What is Novolog (Pharm UP 1966) Ltd.’s market cap?
Novolog (Pharm UP 1966) Ltd.’s market cap is ₪412.79M.
When is Novolog (Pharm UP 1966) Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Novolog (Pharm UP 1966) Ltd.’s earnings last quarter?
Currently, no data Available
Is Novolog (Pharm UP 1966) Ltd. overvalued?
According to Wall Street analysts Novolog (Pharm UP 1966) Ltd.’s price is currently Overvalued.
Does Novolog (Pharm UP 1966) Ltd. pay dividends?
Novolog (Pharm UP 1966) Ltd. pays a Semiannually dividend of 1.957 which represents an annual dividend yield of 4.89%. See more information on Novolog (Pharm UP 1966) Ltd. dividends here
What is Novolog (Pharm UP 1966) Ltd.’s EPS estimate?
Novolog (Pharm UP 1966) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novolog (Pharm UP 1966) Ltd. have?
Novolog (Pharm UP 1966) Ltd. has 510,874,760 shares outstanding.
What happened to Novolog (Pharm UP 1966) Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novolog (Pharm UP 1966) Ltd.?
Currently, no hedge funds are holding shares in IL:NVLG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Novolog (Pharm UP 1966) Ltd.
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. In addition, the company provides appointment scheduling, calendar management, and telemedicine meeting management. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.